Immunologic effects of dioxin: new results from Seveso and comparison with other studies.

Animal studies indicate that the immune system is one of the most sensitive targets of the toxic effects of 2,3,7,8-tetrachloro-p-dibenzodioxin (TCDD). TCDD inhibits immunoglobulin secretion and decreases resistance to bacterial, viral, and parasitic infections in exposed animals. Nearly 20 years after the Seveso, Italy, accident, we measured immunoglobulin and complement plasma levels in a random sample of the population in the most highly exposed zones (n = 62) and in the surrounding noncontaminated area (n = 58). Plasma IgG levels decreased with increasing TCDD plasma concentration (r = -0.35, p = 0.0002). Median IgG concentration decreased from 1,526 mg/dL in the group with the lowest (< 3.5 ppt) TCDD levels to 1,163 mg/dL in the group with the highest (20.1-89.9 ppt) TCDD levels (p = 0.002). The association was significant (p = 0.0004) after adjusting for age, sex, smoking, and consumption of domestic livestock and poultry in multiple regression analysis and persisted after exclusion of subjects with inflammatory diseases and those using antibiotics or nonsteroidal anti-inflammatory drugs. IgM, IgA, C3, and C4 plasma concentrations did not exhibit any consistent association with TCDD levels. We performed a systematic review of all the articles published between 1966 and 2001 on human subjects exposed to TCDD reporting information on circulating levels of immunoglobulins and/or complement components. The literature indicates that the evidence for effects of TCDD on humoral immunity is sparse. Methodologic issues, results, and possible sources of variation between studies are discussed. The possible long-term immunologic effects of TCDD exhibited by the participants of the present study, coupled with the increased incidence of lymphatic tumors in the area of the accident, warrant further investigation.

[1]  L. L. Needham,et al.  Medical evaluation of subjects with known body levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1989, Journal of toxicology and environmental health.

[2]  M. G. Ott,et al.  Morbidity follow up study of BASF employees exposed to 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) after a 1953 chemical reactor incident. , 1994, Occupational and environmental medicine.

[3]  G. Becher,et al.  Halogenated organic compounds and the human immune system: preliminary report on a study in hobby fishermen. , 1996, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[4]  M. G. Ott,et al.  Laboratory results for selected target organs in 138 individuals occupationally exposed to TCDD. , 1994, Chemosphere.

[5]  L L Needham,et al.  High-resolution gas chromatographic/high-resolution mass spectrometric analysis of human serum on a whole-weight and lipid basis for 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1987, Analytical chemistry.

[6]  L. Trümper,et al.  Leukemia- and lymphoma-associated genetic aberrations in healthy individuals , 2002, Annals of Hematology.

[7]  Linda S. Birnbaum,et al.  Consultation on assessment of the health risk of dioxins; re-evaluation of the tolerable daily intake (TDI): executive summary. , 2000, Food additives and contaminants.

[8]  D. Morris,et al.  A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update. , 1991, Toxicology.

[9]  G. Lucier,et al.  Concentrations of dioxin 20 years after Seveso , 1997, The Lancet.

[10]  J. Ward,et al.  Immunological abnormalities 17 years after accidental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1988, British journal of industrial medicine.

[11]  H. Broding,et al.  Chlorinated dibenzo-p-dioxins and dibenzofurans and the human immune system: 3. Plasma immunoglobulins and cytokines of workers with quantified moderately-increased body burdens. , 2000, Life sciences.

[12]  W. Halperin,et al.  Immunological markers among workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1998, Occupational and environmental medicine.

[13]  S. Yufit Role of electronic factors in the formation of a standard, quasi-stable mixture of toxic polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans , 1999 .

[14]  K. Steinberg,et al.  Health effects of long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1986, JAMA.

[15]  N. Kerkvliet,et al.  Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression. , 2001, Toxicology and applied pharmacology.

[16]  F Pocchiari,et al.  HUMAN HEALTH EFFECTS FROM ACCIDENTAL RELEASE OF TETRACHLORODIBENZO‐p‐DIOXIN (TCDD) AT SEVESO, ITALY , 1979, Annals of the New York Academy of Sciences.

[17]  J. Vyfeyken [Serum proteins]. , 1954, Le Scalpel.

[18]  N. Kerkvliet,et al.  Recent advances in understanding the mechanisms of TCDD immunotoxicity. , 2002, International immunopharmacology.

[19]  IgM μ-Chain Antibodies , 2004, Nature Biotechnology.

[20]  J. Michalek,et al.  Serum dioxin and immunologic response in veterans of Operation Ranch Hand. , 1999, American journal of epidemiology.

[21]  P. Bertazzi,et al.  Chemical, Environmental, and Health Aspects of the Seveso, Italy, Accident , 1994 .

[22]  D. Consonni,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin plasma levels in Seveso 20 years after the accident. , 1998, Environmental health perspectives.

[23]  C Zocchetti,et al.  Health effects of dioxin exposure: a 20-year mortality study. , 2001, American journal of epidemiology.

[24]  M. Medwed,et al.  People on the garbage dumps of Cairo: a toxicological in vivo model? , 1995, Central European journal of public health.

[25]  H. Tsuji,et al.  Effects of contamination level of dioxins and related chemicals on thyroid hormone and immune response systems in patients with "Yusho". , 2001, Chemosphere.

[26]  E. Corsini,et al.  Immune parameters in biological monitoring of pesticide exposure: current knowledge and perspectives. , 1999, Toxicology letters.

[27]  C. Tohyama,et al.  Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on T cell-derived cytokine production in ovalbumin (OVA)-immunized C57Bl/6 mice. , 2002, Toxicology.

[28]  N. Kaminski,et al.  Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway. , 2000, The Journal of pharmacology and experimental therapeutics.

[29]  L. Birnbaum,et al.  Non-carcinogenic effects of TCDD in animals , 2000, Food additives and contaminants.

[30]  D. Flesch‐Janys,et al.  Immunologic findings in workers formerly exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners. , 1998, Environmental health perspectives.

[31]  C. Y. Li,et al.  A review of the healthy worker effect in occupational epidemiology. , 1999, Occupational medicine.

[32]  Y. Dragan,et al.  Animal studies addressing the carcinogenicity of TCDD (or related compounds) with an emphasis on tumour promotion , 2000, Food additives and contaminants.

[33]  N. Kerkvliet Immunological effects of chlorinated dibenzo-p-dioxins. , 1995, Environmental health perspectives.